Does STANOZOLOL Cause Secondary hypogonadism? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Secondary hypogonadism have been filed in association with STANOZOLOL. This represents 5.7% of all adverse event reports for STANOZOLOL.
10
Reports of Secondary hypogonadism with STANOZOLOL
5.7%
of all STANOZOLOL reports
0
Deaths
10
Hospitalizations
How Dangerous Is Secondary hypogonadism From STANOZOLOL?
Of the 10 reports, 10 (100.0%) required hospitalization.
Is Secondary hypogonadism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for STANOZOLOL. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does STANOZOLOL Cause?
Drug abuse (93)
Intentional product misuse (30)
Left ventricular hypertrophy (26)
Off label use (17)
Acute kidney injury (15)
Testicular atrophy (15)
Acute myocardial infarction (14)
Toxicity to various agents (14)
Hyperthyroidism (13)
Focal segmental glomerulosclerosis (12)
What Other Drugs Cause Secondary hypogonadism?
TESTOSTERONE (39)
FINASTERIDE (38)
PREDNISONE (23)
ANASTROZOLE (20)
DUPILUMAB (20)
MIRTAZAPINE (20)
OMALIZUMAB (20)
FLUTICASONE FUROATE (19)
TIOTROPIUM (18)
VILANTEROL (18)
Which STANOZOLOL Alternatives Have Lower Secondary hypogonadism Risk?
STANOZOLOL vs STAVUDINE
STANOZOLOL vs STELARA
STANOZOLOL vs STIRIPENTOL
STANOZOLOL vs STIVARGA
STANOZOLOL vs STRATTERA